Loading chat...
TN SB2099
Bill
Status
Passed
4/17/2018
Primary Sponsor
Steven Dickerson
Click for details
AI Summary
Legislative Description
As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.
Controlled Substances
Last Action
Comp. became Pub. Ch. 674
4/17/2018
Committee Referrals
Calendar3/7/2018
Health and Welfare2/28/2018
Judiciary2/5/2018
Full Bill Text
No bill text available